Isoprorenol promotes tumor angiogenesis by activating the PlexinA1/VEGFR2-JAK2-STAT3 signal transduction pathway within human umbilical vein endothelial cells (HUVECs), which may be a candidate target for the development of an anti-tumor angiogenesis strategy (28). The gene discussed is STAT3; the disease is neoplasm.